Yorkshire Lung Screening Trial (YLST) pathway navigation study: a protocol for a nested randomised controlled trial to evaluate the effect of a pathway navigation intervention on lung cancer screening uptake

Yorkshire Lung Screening Trial (YLST) Pathway Navigation Study

A Protocol for a Nested Randomised Controlled Trial to Evaluate the Effect of a Pathway Navigation Intervention on Lung Cancer Screening Uptake

BMJ Open. 2024 Jul 9;14(7):e084577. doi: 10.1136/bmjopen-2024-084577.

Introduction: Lung cancer is a leading cause of cancer death worldwide. The UK National Screening Committee recommended a national targeted lung cancer screening programme in 2022 to improve early diagnosis and survival rates. However, there are socioeconomic and smoking-related disparities in screening uptake. This trial aims to assess whether a pathway navigation intervention can increase participation in lung cancer screening.

Methods and Analysis: The trial involves a two-arm randomised controlled trial and process evaluation within the YLST. Participants aged 55-80 who have not responded to previous postal invitations to screening will be randomised to receive pathway navigation or usual care. The pathway navigation intervention includes a postal appointment notification and prearranged telephone appointment with a trained navigator to guide participants through the screening process.

Primary Outcomes: The number undergoing initial telephone assessment of lung cancer risk and the number undergoing a lung cancer screening scan. Secondary outcomes include demographic, clinical, and risk parameters of participants undergoing the assessment, as well as the number of screen-detected cancers diagnosed and costs.

Ethics and Dissemination: The study is approved by the Greater Manchester West Research Ethics Committee and the Health Research Authority. Results will be shared through peer-reviewed scientific journals, conference presentations, and the YLST website.

Trial Registration Numbers: ISRCTN42704678 and NCT03750110.

Clinical Trials and AI-Driven Solutions

Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians. In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally. By using AI, clinics can enhance their workflows, improve patient outcomes, and reduce paper routines. Learn more about how we can help at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.